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ABSTRACT 
CONTEXT AND OBJECTIVES: Osteoporosis has frequently been observed in patients with rheumatoid arthritis. The present study was undertaken in order 
to evaluate factors associated with osteoporosis among women with rheumatoid arthritis. 
DESIGN AND SETTING: Cross-sectional study, carried out in a public hospital in São Paulo. 
METHODS: The participants were 83 women with rheumatoid arthritis (53.7 ± 10.0 years old). Bone mineral density (BMD) and body composition were 
measured by dual energy X-ray absorptiometry. The patients were divided into three groups according to BMD: group 1, normal BMD (n = 24); group 2, 
osteopenia (n = 38); and group 3, osteoporosis (n = 21). Tests were performed to compare differences in means and correlations, with adjustments for 
age, duration of disease and cumulative corticosteroid. The relationships between clinical factors, physical activity score, dietary intake, body composition 
and biochemical parameters were analyzed using linear regression models. 
RESULTS: Mean calcium, vitamin D and omega-6 intakes were lower than the recommendations. Associations were found between BMD and age, disease 
duration, parathyroid hormone concentration and fat intake. The linear regression model showed that being older, with more years of disease and lower 
weight were negatively correlated with BMD [Total femur = 0.552 + 0.06 (weight) + 0.019 (total physical activity) – 0.05 (age) – 0.003 (disease duration); 
R2 = 48.1; P < 0.001]. 
CONCLUSION: The present study indicates that nutritional factors and body composition are associated with bone mass in women with rheumatoid 
arthritis. 
RESUMO
CONTEXTO E OBJETIVO: A osteoporose é frequentemente observada em pacientes com artrite reumatoide (AR). O presente estudo foi realizado com o 
objetivo de avaliar fatores associados a osteoporose em mulheres com AR.  
TIPO DE ESTUDO E LOCAL: Estudo transversal realizado em um hospital público em São Paulo.
MÉTODOS: Participaram 83 mulheres com AR (53.7 ± 10.0 anos). A densidade mineral óssea (DMO) e composição corporal foram mensuradas pelo 
método de densitômetro de dupla emissão com fonte de raios-X. Houve a divisão em grupos conforme a DMO: grupo 1 DMO normal (n = 24); grupo 2 
osteopenia (n = 38) e grupo 3 osteoporose (n = 21). Foram realizados testes para comparar diferenças de médias e correlações ajustadas para idade, 
duração da doença e corticosteroide acumulado. A relação entre fatores clínicos, escore de atividade física, consumo alimentar, composição corporal e 
parâmetros bioquímicos foram analisados pelo modelo de regressão linear.
RESULTADOS: A média de consumo de cálcio, vitamina D e ômega-6 esteve abaixo do recomendado. Houve associação entre DMO e idade, duração da 
doença, hormônio da paratireóide (PTH) e consumo de gordura. O modelo de regressão linear evidenciou que ser mais velho, apresentar mais anos de 
doença e menor peso correlacionam-se negativamente com a DMO. [Fêmur total = 0.552 + 0.06 (peso) + 0.019 (atividade física total) – 0.05 (idade) 
– 0.003 (duração da doença), R2 = 48.1; P < 0.001].
CONCLUSÃO: O presente estudo indica que fatores nutricionais e de composição corporal estão associados com a massa óssea em mulheres com AR. 
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INTRODUCTION
Rheumatoid arthritis is a chronic inflammatory and destructive 
joint disease that affects 0.5-1% of the world’s population and com-
monly leads to significant disability and consequent impairment of 
quality of life.1-2 It is two or three times more frequent in women than 
in men and can start at any age, with its peak incidence between the 
fourth and sixth decades of life.3
Generalized osteoporosis is an extra-articular complication of rheuma-
toid arthritis that results in increased risk of fractures and associated mor-
bidity, mortality, and healthcare costs.4 The incidence of osteoporosis among 
patients with rheumatoid arthritis is 15-20% at the hip and spine.5
Bone metabolism in rheumatoid arthritis cases is altered by the 
chronic inflammatory process, via activation/inhibition of bone cell 
function,6 modification of body composition, corticosteroid use,7 diet8 
and low levels of physical activity.
Moreover, during the active phase of the disease, elevated plasma 
concentrations of inflammatory cytokines, i.e. interleukin-1 (IL-1), in-
terleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) lead to re-
ductions in fat-free mass with a loss of body cell mass and consequent 
reduction in muscle strength.9 This loss may negatively affect bone min-
eral density (BMD), because lean mass has been reported to be a predic-
tor of bone mass through its mechanical pull on the skeleton.10
Corticosteroid treatment presents a relative contribution, since it 
also induces osteoporosis by several mechanisms, such as through de-
creased calcium absorption, increased renal calcium excretion and inhi-
bition of estrogen production in women, with direct and indirect effects 
on osteoblast and osteoclast function.7
The role of diet in rheumatoid arthritis and bone metabolism has 
been widely investigated, especially calcium, vitamin D, protein and lip-
id intake. The positive effects of adequate calcium and vitamin D intake 
on bone metabolism, through downregulation of serum parathyroid 
hormone (PTH) levels have been well established.11 It has also been well 
recognized that proteins have a beneficial effect on bone mass, inasmuch 
as bone tissue is formed by protein.12 A substantial fraction of the ami-
no acids in bone collagen cannot be reutilized in new protein synthesis. 
Hence, bone turnover requires continuous intake of new protein.13
Some research has suggested that dietary lipids may also be impor-
tant for bone health in rheumatoid arthritis cases, since there is a notable 
link between increased lipid peroxidation and bone loss.14,15 Also, two 
types of polyunsaturated fatty acids (ω-3 and ω-6) influence bone me-
tabolism.16 Higher ω-3 fatty acid intake enhances calcium absorption, 
decreases calcium loss and increases bone calcium.17-19 In addition, inhibi-
tion of cytokine production has been implicated as a potential mechanism 
for the favorable effects of fatty acids on bone.20,21 On the other hand, a 
higher ω-6/ω-3 ratio is associated with lower BMD22 while, in rheuma-
toid arthritis patients, a lower ω-6/ω-3 ratio suppresses the inflammatory 
cytokines,23,24 which could therefore benefit bone metabolism.
OBJECTIVE
The present study was undertaken in order to evaluate factors asso-
ciated with osteoporosis among women with rheumatoid arthritis. 
MATERIALS AND METHODS
Subjects
This was a cross-sectional study with a convenience sample that was 
performed in a rheumatology outpatient clinic at a public hospital, He-
liópolis Hospital, São Paulo, from June 2005 to January 2006. Patients 
under 18 years of age, male patients, pregnant women, patients who had 
diseases causing significant nutritional status impairment (neoplasia, 
end-stage renal failure, cardiovascular and gastrointestinal disease, such 
as aneurysm, angina, congestive heart failure, ischemic heart disease, 
stroke, inflammatory bowel disease, lactose intolerance and celiac dis-
ease) and patients with a history of chronic alcoholism were excluded. 
One hundred and twenty women were evaluated. Thirty were exclud-
ed because they did not fulfill the necessary criteria for this study and an-
other seven were excluded because they presented locomotion difficulty. 
Thus, 83 women who fulfilled the American College of Rheumatology25 
criteria for rheumatoid arthritis and agreed to participate were included 
in the present analysis. Participants’ eligibility was assessed by a physician. 
The mean age (± standard deviation, SD) of the patients was 53.7 ± 10.0 
years and they had had the disease for a mean of 7.7 ± 6.5 years. 
The subjects were divided into three groups in accordance with 
World Health Organization (WHO) criteria for low bone mass: group 
1, normal BMD (n = 24); group 2, osteopenia (n = 38); and group 3, 
osteoporosis (n = 21).26 The estimated sample size was 44, based on a 
1% prevalence of rheumatoid arthritis in the general population, stan-
dard error of 1.5% and type 1 (α) error of 0.05.27 The study protocol 
was approved by the ethics committees of Universidade de São Paulo 
and Heliópolis Hospital, and an informed consent statement was signed 
by each participant.
Clinical data collection
Standardized questionnaires were used to ascertain demograph-
ic characteristics, medical history and use of oral glucocorticosteroids. 
Functional status was assessed using the Health Assessment Question-
naire (HAQ) score28 and disease activity was assessed using the Disease 
Activity Score-28 (DAS-28).29
Dietary assessment
Dietary intake was assessed by using a validated food frequency 
questionnaire with 62 food items.30 This food questionnaire was admin-
istered by a trained nutritionist and provided information about food 
consumption over the preceding six months. The Dietary Analysis Sys-
tem (Dietsys) software, version 4.0 (National Cancer Institute, Bethes-
da, United States), was used to calculate nutrient intake. Mean daily in-
take, including total energy (kcal/day), total macronutrients, calcium, 
vitamin D and fatty acids were evaluated. The nutrients were adjusted 
for energy in accordance with Willett and Stampfer.31 Nutritional in-
takes were compared with the recommendations of the Food and Nutri-
tion Board’s dietary reference intakes.32,33
Physical activity assessment
Physical activity was assessed using the Baecke Questionnaire of 
Habitual Physical Activity.34 All subjects completed the questionnaires. 
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Normal physical activity was assessed using three components: work, 
sport and leisure. All responses, with the exception of occupation activ-
ity and type of sport played, were precoded on a five-point scale, with 
descriptors ranging from never (1) to very often (5). Occupational ac-
tivity was scored as low-level (1), middle-level (3) or high-level (5) activ-
ity. The sport score was calculated as (intensity code x duration code x 
code for proportion of the year) x 1.25. Each activity component could 
receive a maximum of five points, thereby giving a maximum of 15 for 
the physical activity index. Each index was rounded to the nearest tenth 
of a point.
Anthropometry
The subjects were weighed on balance beam scales to the nearest 
0.1 kg. Standing height was measured on the stadiometer of the balance, 
to the nearest centimeter. Body mass index was calculated as weight/
height2 (kg/m2).
Body composition and bone mineral density assessment
BMD measurements were performed on the lumbar spine (L1-L4) 
and femur by using dual energy X-ray absorptiometry (GE-Lunar Ra-
diation Corporation, DPX IQ, Madison, United States). The device was 
calibrated daily and had a coefficient of variation of 1.5% for the spine 
and femur. Osteoporosis was defined as a T-Score ≤ -2.5, and osteopenia 
was defined as a T-Score between -1 and -2.5.26
Percentage of total body fat (%BF), total fat-free mass, and appen-
dicular lean mass were measured using the same methodology (GE-Lu-
nar Radiation Corporation, DPX IQ, Madison, United States). The rel-
ative skeletal muscle index (RSMI) was derived from the appendicular 
lean mass (kg) divided by the square of the height (m2). Sarcopenia was 
defined as RSMI of two standard deviations below the sex-specific mean 
for a young healthy reference population (< 5.45 kg/m2 for women).35
Biochemical analysis
Blood samples were drawn from the patients after four hours of 
fasting. Serum intact parathyroid hormone (iPTH; normal range 15 - 
65 pg/ml) was measured by using an electrochemiluminescence meth-
od. Serum total calcium (normal range 8.4-10.2 mg/dl) was measured 
by using a colorimetric assay and serum phosphorus (normal range 2.4-
4.6 mg/dl) was measured by using UV mobility. C-reactive protein 
(CRP) was measured by means of latex agglutination (normal range: 
greater than 0.5 mg/dl), and the erythrocyte sedimentation rate was 
measured using the Westergren method (normal range: up to 10 mm 
in the first hour). Serum osteoprotegerin was determined using the En-
zyme-Linked ImmunoSorbent Assay (ELISA) method (Alpco Diagnos-
tics, Windham, United States) Seropositivity for rheumatoid factor was 
ascertained by means of the Singer-Plotz latex agglutination test. The 
analyses were performed at the hospital laboratory.
Statistical analysis
Results were expressed as means and standard deviations. Statisti-
cal analyses were performed using SAS for Windows (Statistical Analy-
sis System), version 8.02. (SAS Institute Inc, 1999-2001, Cary, United 
States) and the Statistical Package for the Social Sciences, version 11.5 
for Windows (SPSS Inc, Chicago, United States). The sample power 
was calculated according to the single proportion test.27 The significance 
level taken was 5%.
Differences between groups were evaluated by means of analysis of 
variance (ANOVA). Analysis of covariance (ANCOVA) with age, dura-
tion of disease and cumulative prednisone use as covariates was also per-
formed. Parametric and nonparametric tests were used in accordance 
with the type of variable distribution, for mean difference compari-
sons and correlation tests. Linear regression models were used to iden-
tify possible factors relating to BMD (dependent variable). The general 
and clinical features, dietary intake data, physical activity scores, body 
composition measurements and biochemical parameter concentrations 
were independent variables. All variables showing significant correla-
tions with BMD were tested using a stepwise method. P-values of < 
0.05 were considered significant.
RESULTS
The demographic and clinical characteristics (mean ± standard devi-
ation) of the 83 patients are reported in Table 1. The osteoporotic wom-
en were significantly older and had had the disease for longer times. In-
flammatory activity was classified as moderate in all groups. No statisti-
cally significant differences were found in mean HAQ and total physical 
activity scores. A significant difference was observed regarding cumula-
tive prednisone dose: women with osteopenia had higher cumulative 
doses than did those with normal BMD (P < 0.05). No significant dif-
ferences were observed in current prednisone doses.
Body mass index (BMI), total fat-free mass, appendicular lean mass 
and body fat were lower in the osteoporosis BMD group (P < 0.05). 
Only one subject in the osteoporosis BMD group was classified as sar-
copenic.
The dietary intakes are presented in Table 2. No statistically signifi-
cant differences were found in mean daily energy, protein, calcium, vi-
tamin D and fatty acid intake. On the other hand, mean daily fat intake 
was significantly higher among osteoporotic women than among others. 
The mean daily ω-6/ω-3 ratio was higher in the osteopenia group than 
in the normal BMD group (P < 0.05), and the mean daily carbohydrate 
intake was lower in the osteopenia BMD group than in the normal 
BMD group (P < 0.05). In all groups, mean macronutrient and ω-3 in-
take were within the ranges proposed by the Food and Nutrition Board 
for dietary reference intakes.32 Mean calcium, vitamin D and ω-6 in-
takes were lower than the proposed dietary reference intake values.32,33
Among the biochemical parameters (Table 3), the mean serum to-
tal calcium was higher in the normal BMD group than in the osteope-
nia group, despite remaining within the normal range. The serum phos-
phorus and iPTH were within their respective normal ranges, and there 
were no significant differences between the groups. The mean osteopro-
tegerin concentration was significantly higher among the women with 
osteoporosis.
The significant correlations between BMD and different variables 
are presented in Table 4. BMD presented negative correlations with age 
and disease duration at all sites evaluated. There was also a negative cor-
relation between serum iPTH and BMD (P < 0.05, r = -0.24). Never-
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Variable
Normal BMD Osteopenia BMD Osteoporosis BMD
Pn = 24 n = 38 n = 21
Mean (SD) Mean (SD) Mean (SD)
Age (years) 49.9 ± 9.6 52.1 ± 9.4 61.0 ± 7.8 *† < 0.001
Disease duration (years) 5.1 ± 4.5 8.0 ± 7.6 10.2 ± 5.5 *† 0.030
BMI (kg/m2) 29.6 ± 5.7 26.8 ± 4.9 23.4 ± 3.6*† < 0.001
DAS-28 (score) 4.8 ± 1.3 4.9 ± 1.2 4.5 ± 1.3 0.498
HAQ (score) 0.9 ± 0.7 1.1 ± 0.8 0.8 ± 0.7 0.368
Work index (score) 3.1 ±0.5 2.9 ± 0.5 2.6 ± 0.5 0.125
Sport index (score) 2.2 ± 0.6 2.0 ± 0.6 2.0 ± 0.5 0.273
Leisure index (score) 7.4 ± 1.5 6.7 ± 1.4 7.0 ± 1.8 0.326
Total physical activity index (score) 12.8 ± 1.9 11.7 ± 1.8 11.7 ± 2.2 0.171
Current prednisone (mg) 5.7 ± 4.7 5.7 ± 3.0 4.8 ± 3.4 0.586
Cumulative prednisone (mg) 2706.3 ± 2121.3 4219.0 ± 2272.8‡ 3631.8 ± 2102.6 0.034
Lumbar spine BMD (g/cm2) 1.202 ± 0.098 1.019 ± 0.102‡ 0.852 ± 0.096*† < 0.001
Femoral neck BMD (g/cm2) 1.037 ± 0.119 0.847 ± 0.082‡ 0.657 ± 0.085*† < 0.001
Total femur BMD (g/cm2) 1.066 ± 0.110 0.879 ± 0.079‡ 0.678 ± 0.078*† < 0.001
Total fat-free mass (g) 44471.7 ± 4839.5 41407.7 ± 5157.2‡ 37194.3 ± 4162.7*† < 0.001
Appendicular lean mass (kg) 20934.6 ± 2489.8 19272.8 ± 2752.7‡ 16404.4 ± 2516.8*† < 0.001
RSMI (kg/m2) 8.6 ± 0.9 8.0  ± 1.1 7.4 ± 0.9*† < 0.001
Body fat (%) 34.6 ± 7.4 32.4 ± 8.0 28.3 ± 6.7* 0.008
Table 1. General and clinical features of the population studied, according to bone mineral density (BMD)
*P < 0.05 versus normal BMD; 
†P < 0.05 versus osteopenia BMD; ‡P < 0.05 versus osteoporosis BMD; DAS-28 = Disease activity score 28; HAQ = Health Assessment Questionnaire; BMI = Body mass index; RSMI = Relative Skeletal 
Muscle Index; ANCOVA (analysis of covariance) = adjustments for age, disease duration and cumulative prednisone; SD = standard deviation.
Variable
Normal BMD Osteopenia BMD Osteoporosis BMD
Pn = 24 n = 38 n = 21
Mean (SD) Mean (SD) Mean (SD)
Energy (kcal) 1421.1 ± 336.3 1528.7 ± 439.5 1646.0 ± 436.4 0.195
Carbohydrate (%) 59.5 ± 5.1 55.2 ± 6.6* 52.8 ± 5.5 0.004
Protein (%) 16.2 ± 2.3 17.0 ± 3.3 15.2 ± 2.8 0.527
Fat (%) 24.2 ± 5.5† 29.1 ± 5.1*† 26.6 ± 5.1‡ 0.006
ω-3 (g/day) 1.0 ± 0.5 1.0 ± 0.4 1.1 ± 0.4 0.463
ω-6 (g/day) 6.3 ± 3.3 7.1 ± 2.5 7.2 ± 2.4 0.450
ω-6/ω-3 (g/day) 6.3 ± 1.4 7.2 ± 1.5* 6.7 ± 1.2 0.045
Calcium (mg/day) 597.3 ± 281.7 655.3 ± 254.0 696.2 ± 217.1 0.492
Vitamin D (IU/day) 60.7 ± 56.9 66.6 ± 62.3 88.1 ± 89.6 0.148
Table 2. Dietary intake and biochemical parameters of the study population, according to bone mineral density
*P < 0.05 versus osteoporosis BMD; †P < 0.05 versus osteopenia; ‡P < 0.05 versus normal BMD; ω -3: omega-3; ω -6: omega-6. Protein, fat, carbohydrate, calcium and phosphorus were adjusted for energy. ANCOVA (analysis of 
covariance): adjustments for age, disease duration and cumulative prednisone. SD = standard deviation.
Variable
Normal BMD Osteopenia BMD Osteoporosis BMD
Pn = 24 n = 38 n = 21
Mean (SD) Mean (SD) Mean (SD)
Serum total calcium (mg/dl) 9.0 ± 0.6 8.4 ± 0.7* 8.7 ± 0.7 0.024
Serum phosphorus (mg/dl) 3.7 ± 0.9 3.4 ± 0.7 3.7 ± 1.2 0.309
Serum intact PTH (pg/ml) 28.9 ±10.3 34.5 ±11.0 32.9 ± 8.9 0.142
Serum osteoprotegerin (pg/ml) 78.6 ± 79.9 72.5 ± 48.8 122.6 ± 87.6†,‡ 0.036
Table 3. Biochemical parameters of the study population, according to bone mineral density
*P < 0.05 versus osteoporosis BMD; †P < 0.05 versus normal BMD; 
‡P < 0.05 versus osteopenia; SD = standard deviation. ANCOVA (analysis of covariance): adjustments for age, disease duration and cumulative prednisone.
theless, physical activity work index, total physical activity, BMI, lean 
mass and fat mass were positively correlated with BMD.
Table 5 presents the multiple linear regression models for lumbar 
spine, femoral neck and total femur BMD. Adjustments for possible inter-
actions and potential confounders were made for vitamin D, calcium in-
take, weight, physical activity and corticosteroid use. It was found that age 
and disease duration were independent deleterious risk factors for BMD, 
at all skeletal sites. Fat intake and iPTH were also considered to be nega-
tive risk factors for lower spine BMD and femoral neck BMD, respective-
ly. Weight had a positive effect on spine BMD. Weight, appendicular lean 
mass and total physical activity had a positive effect on femur BMD.
DISCUSSION
This was the first study to evaluate the relationship between nutri-
tional factors and body composition in relation to bone mineral density 
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among rheumatoid arthritis patients. Fat intake, age, disease duration 
and serum iPTH were variables associated with low bone mass among 
female rheumatoid arthritis patients. 
Body composition and age have been associated with BMD. Lean 
mass and fat mass play a positive role in relation to bone mass. The as-
sociation between lean mass and bone mass may be due to mechanical 
load forces on bone. Moreover, fat mass is metabolically active, and in-
creases BMD through hormonal metabolism of adipocytes, thereby in-
tervening in osteoblast/osteoclast function.11
In the present study, osteoporotic women had significantly lower 
fat and lean mass. In part, this may be explained by the inflammatory 
process, with production of cytokines such as TNFα and higher protein 
breakdown.36,37 One efficient way to ensure adequate lean mass in the 
body composition is through physical activity. The low physical activ-
ity levels among rheumatoid arthritis patients may contribute towards 
losses in bone and lean mass. In fact, physical activity levels were related 
to BMD among our patients, since a positive correlation was observed 
between the physical activity score and the lumbar spine and total femur 
BMD, thus suggesting that an improvement in physical activity levels 
could have a beneficial effect.
The relationship between age and bone loss among rheumatoid arthri-
tis patients has also been observed by another investigator.38 This relation-
ship was expected, because older women have been exposed for greater 
lengths of time to risk factors for bone loss such as corticosteroid use, lower 
estrogen levels, prolonged immobilization and greater inflammatory state. 
There is disagreement concerning the effects of glucocorticoids on bone 
mass in rheumatoid arthritis cases.38,39 In the present study, glucocorticoids 
had no association with BMD: this may have been due to the low dose ad-
ministered. Moreover, the osteopenic women showed higher cumulative 
prednisone levels. In a study by Dykman40 using single-photon absorpti-
ometry and previous corticosteroid therapy, multivariate analysis on BMD 
data clearly demonstrated clearly that the cumulative dose of prednisolone 
was the most important factor determining corticosteroid osteopenia. 
Energy intake did not present significant differences between the 
groups, and no changes were observed in physical activity levels. Fur-
thermore, patients with reduced bone mass presented low body fat and 
lean mass, thereby indicating that these patients might have an abnor-
mal basal metabolic rate.
Stone et al.8 observed similar fat intake in rheumatoid arthritis pa-
tients. Inverse correlations between fat intake and BMD could be ex-
plained in terms of increased saturated and trans fat levels, thereby caus-
ing increases in oxidative stress. Thus, free radicals may increase osteo-
clastogenesis and bone resorption through activation of the receptor ac-
tivator of nuclear factor kappa B (RANK) ligand (RANKL).14
No significant associations were observed between calcium, vita-
min D and fatty acid intakes and BMD. Calcium and vitamin D in-
takes were lower than the proposed values for bone loss prevention.34 
In this regard, natural food sources are scarce and Brazilian foods are 
not fortified with vitamin D. Studies conducted among Brazilian pop-
ulations have observed lower levels of circulating 25(OH)D,41 thus in-
dicating that sun exposure and diet alone are not enough to main-
tain vitamin D adequacy. However, prospective follow-up studies are 
needed in order to determine the calcium and vitamin D intake levels 
needed to maintain adequate bone metabolism in rheumatoid arthri-
tis patients.
The average ω-3 fatty acid intake in all groups was adequate. On 
the other hand, the opposite was observed for ω-6 fatty acids. Despite 
this, the ω-6/ω-3 fatty acid ratio found in the present study was in-
adequate in all groups evaluated. Over recent years, there has been a 
marked increase in the consumption of ω-6 fatty acids and the ω-6/ω-3 
ratio has increased dramatically.42 For rheumatoid arthritis patients, the 
recommended ω-6/ω-3 ratio is between 2:1 and 3:1, in order to sup-
press the inflammation.23,24 In our population, a higher ratio was ob-
served, and this might increase the production of inflammatory cytok-
ines, since ω-6 fatty acids are involved in the synthesis of prostaglandin 
E2, while ω-3 fatty acids inhibit its production.17,43,44
Variable
L1-L4 (g/cm2) BMD Femoral neck (g/cm2) BMD Total femur (g/cm2) BMD
r (P) r (P) r (P)
Age (years) -0.37 (0.001) -0.42 (< 0.001) -0.35 (0.001)
Disease duration (years) -0.41 (< 0.001) -0.23 (0.034) -0.26 (0.016)
BMI (kg/m2) 0.39 (< 0.001) 0.44 (< 0.001) 0.49 (< 0.001)
Total fat-free mass (kg) 0.36 (0.001) 0.53 (< 0.001) 0.57 (< 0.001)
Appendicular lean mass (kg) 0.37 (0.001) 0.54 (< 0.001) 0.59 (< 0.001)
RSMI (kg/m2) 0.31 (0.004) 0.47 (< 0.001) 0.54 (< 0.001)
Body fat (%) 0.33 (0.002) 0.30 (0.005) 0.31 (0.004)
Work index (score) 0.32 (0.003) 0.36 (0.001) 0.38 (< 0.001)
Total physical activity index (score) 0.23 (0.033) 0.20 (0.07) 0.26 (0.018)
Fat (%) -0.29 (0.007) -0.23 (0.039) -0.22 (0.047)
iPTH (pg/ml) n = 80 -0.11 (0.326) -0.24 (0.032) -0.19 (0.099)
Table 4. Significant correlations between bone mineral density and different variables among the women with rheumatoid arthritis
L1-L4 = lumbar spine vertebral 1 to 4; BMD = bone mineral density; BMI = body mass index; RSMI = relative skeletal muscle index; iPTH = intact parathyroid hormone. Pearson’s correlation. 
Equations R R2 adjusted P
Lumbar spine BMD model = 1.153 + 0.005 (W) - 0.005 (D) - 0.004 (A) - 0.003 (FI) 0.626 0.360 0.000
Femoral neck BMD model = 0.764 + 0.000 (ALM) - 0.005 (A) - 0.005 (D) - 0.003 (PTH) 0.698 0.460 0.000
Total femur BMD model = 0.552 + 0.06 (W) + 0.019 (TPA) - 0.05 (A) - 0.003 (D) 0.711 0.481 0.000
Table 5. Regression equations for estimates at the bone sites evaluated among the women with rheumatoid arthritis
BMD = bone mineral density; W = weight; D = disease duration; A = age; FI = fat intake (%); ALM = appendicular lean mass; PTH = parathyroid hormone; TPA = total physical activity.
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Serum osteoprotegerin, iPTH, calcium and phosphorus were with-
in the normal range in all the groups evaluated. The osteopenic women 
presented lower serum calcium and higher iPTH compared with the 
other groups. iPTH was negatively and significantly associated with 
bone mass in the linear regression model for the femoral neck. Other 
authors45,46 have found negative correlations between PTH and BMD 
among rheumatoid arthritis patients. PTH therapy directly stimulates 
osteoblastogenesis and inhibits osteoblast apoptosis. Recently, Saag et 
al.47 demonstrated that teriparatide had significant skeletal benefits (in-
creased BMD and decreased new vertebral fractures) among patients 
with glucocorticoid-induced osteoporosis.
Osteoprotegerin levels are frequently higher in individuals with 
osteoporosis,48 as was observed among our patients. Masi et al.48 sug-
gested that patients with greater disease severity could have higher lev-
els of serum osteoprotegerin because of a compensatory self-defense re-
sponse for keeping control over the immune mechanisms that are re-
sponsible for bone and cartilage destruction. Recent data have indicated 
that denosumab, a fully human monoclonal antibody against RANKL, 
is able to inhibit RANKL-RANK interaction, thereby mimicking the 
endogenous effects of osteoprotegerin. Thus, it may be used to treat 
osteoporosis and periarticular bone loss and to decrease bone erosions 
in rheumatoid arthritis cases, although this antagonism does not treat 
synovitis.49
The present study has some limitations, such as the absence of mea-
surements on basal energy expenditure, biochemical markers for pro-in-
flammatory cytokines and serum 25(OH)D, given that the changes in 
bone mass and body composition were due to inflammatory processes. 
In addition, osteoporotic fractures were not evaluated. Although the de-
sign of this study only allowed hypotheses of associations to be raised, 
it was demonstrated that body composition and nutrient intake were 
associated with BMD among patients with rheumatoid arthritis. Thus, 
health professionals should include nutritional and physical activity ad-
vice in the management of rheumatoid arthritis patients.
CONCLUSION
In summary, the present study indicates that nutritional factors and 
body composition are important modifiable factors that can improve 
bone mass and prevent osteoporotic fractures in rheumatoid arthritis 
patients. 
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